![Memorial Sloan Kettering medical oncologist Diane Reidy Lagunes](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/518/3x2/180221-km-msk-lagunes-26r_1200x800.jpg?h=10d202d3)
Diane Reidy-Lagunes, MD
Gastrointestinal Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Gastrointestinal Oncology
- Neuroendocrine Tumors
- Colon, Appendix, Pancreas, Gallbladder, and Bile Duct Tumors
Request an Appointment
About Me
- Vice Chair of Oncology Operations, Regional Care Network
- Past President, MSK Medical Staff
- Creator and Host, Cancer Straight Talk Podcast
I am a medical oncologist who cares for people with gastrointestinal and endocrine cancers, including neuroendocrine, adrenal, colon, appendix, and pancreatic cancers, and cholangiocarcinoma.
I joined Memorial Sloan Kettering Cancer Center in 2008 and work as part of a team of experts who have chosen to dedicate their passion, knowledge, and experience to caring for people affected by these cancers.
Read more
Many of the cancers I treat have tremendous differences in their behavior. It’s my job and responsibility to ensure that my patients receive the best treatments delivered in the best ways possible. This requires a personalized approach. It’s also my job to be an advocate and to guide my patients through a very difficult time. We are on the journey together.
My research is focused on finding methods to use a molecular-based approach to treat neuroendocrine and adrenocortical cancers. Our goals and our North Star are to allow our patients to live happier, healthier, and longer lives. At MSK, our team is proud to be making great strides in how we care for people with these diseases.
One of them is our Cancer Straight Talk Podcast. I am the creator and host of the podcast, which brings together national experts and patients with cancer to have straightforward, evidence-based conversations. Through the podcast, I hope to educate and empower patients with information that can help them make the best decisions related to their individual care goals and ultimately, live happier, healthier lives.
Since its first episode aired in September 2020, Cancer Straight Talk has covered a variety of topics, ranging from financial toxicity to the role of health and exercise. When patients come to MSK, they have a lot of questions about their diagnosis and treatment plan. Many of the subjects that we talk about on Cancer Straight Talk might not come up in clinic for a variety of reasons; for instance, in the midst of the surprise that often comes with a cancer diagnosis, patients might not think to ask about health and exercise. Similarly, some patients might not know what financial toxicity is or how to start a conversation about it. I developed Cancer Straight Talk to not only help patients through a difficult time, but to also provide a safe place for education and understanding that cares for the whole patient, both in and outside of the clinic.
A new episode of Cancer Straight Talk becomes available at the end of each month. Stream Cancer Straight Talk below (with four episodes available in Spanish):
If you have questions, feedback, or topic ideas for upcoming episodes, please e-mail them to: [email protected]
A gastrointestinal (GAS-troh-in-TES-tih-nul) oncologist is a cancer doctor with special training in the gastrointestinal (GI) system. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
My Specialties
- Gastrointestinal Oncology
- Neuroendocrine Tumors
- Colon, Appendix, Pancreas, Gallbladder, and Bile Duct Tumors
Education
- MD, SUNY Downstate at Brooklyn
Residencies
- Internal Medicine - Mount Sinai Hospital
Awards and Honors
- Castle Connolly: Exceptional Women in Medicine (2024)
- Castle Connolly: America’s Top Doctor (2024)
- Medical Honoree Award, American Cancer Society (2023)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Exceptional Women in Medicine Award, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Paul Sherlock Resident House Staff Teaching Award
- Castle Connolly: New York Magazine Top Doctors (2017-2022)
- The American Cancer Society Mother of the Year Award
- Society of MSK Dream Team Honoree
Fellowships
- Medical Oncology/Hematology - Memorial Sloan Kettering Cancer Center
- Medicine - Weill Cornell Medical College
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/131881/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
New Patients
Current Patients
Contact and Location
Dr. Reidy-Lagunes sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Reidy-Lagunes
- A Phase I Study of 177Lu-DOTA-EB-TATE in People with Advanced Neuroendocrine Cancers
- A Phase II Study of Temozolomide and Olaparib to Treat Advanced Pheochromocytoma and Paraganglioma
- A Study Comparing Lutetium Edotreotide with Standard Treatments in People with Digestive Neuroendocrine Tumors
- A Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Reidy-Lagunes’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Diane Reidy-Lagunes discloses the following relationships and financial interests:
-
Advanced Accelerator Applications USA
Professional Services and Activities -
Bind Benefits Inc.
Professional Services and Activities -
Chiasma, Inc.
Professional Services and Activities
-
Ipsen Pharma
Professional Services and Activities -
Lexicon Pharmaceuticals
Professional Services and Activities -
Novartis
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].